Učitavanje...
Head and Neck Cancer Immunotherapy beyond the Checkpoint Blockade
The success of immune checkpoint receptor blockade has brought exciting promises for the treatment of head and neck squamous cell carcinoma (HNSCC). While patients who respond to checkpoint inhibitors tend to develop a durable response, <15% of patients with HNSCC respond to immune checkpoint inh...
Spremljeno u:
| Izdano u: | J Dent Res |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6704427/ https://ncbi.nlm.nih.gov/pubmed/31340724 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0022034519864112 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|